CV Sciences, Inc.
CVSI· OTC
CVSICV Sciences, Inc.
Released Nov 14, 2024, before the open
10-Q filed Nov 14, 2024, 45 days after period end · 0000950170-24-127040
| Metric | Q3 2024 | Q3 2023 | Q3 2022 | Q3 2021 |
|---|---|---|---|---|
| Revenue | $3.87M | $4.09M | $3.75M | $5.11M |
| Net Income | -$456.00K | -$447.00K | -$1.03M | -$40.00K |
| EPS Diluted |
CV Sciences, Inc. · CIK 1510964 · Engraved from SEC EDGAR
| $0.00 |
| $0.00 |
| -$0.01 |
| $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
